Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on July 23, 2025
Dr. Adriana Lombardi Redefines Dermatologic Care at The Skin Cancer & Cosmetic Surgery Center of New Jersey
EIN Presswire
·
July 23, 2025
NJ Top Docs has reviewed and approved Dr. Adriana Lombardi based on merit for 2025. EDISON, NJ, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- Since founding The Skin Cancer …
Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …
Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide
GlobeNewswire
·
July 23, 2025
Plans to initiate Phase 2 clinical trial in Adrenocortical Carcinoma in early 2026 through unique partnership between Cytovation, Cancer Research UK and the Norwegian Cancer Society Bergen, Norway, July 23, 2025 – Cytovation ASA, a clinical stage oncology …
Ipsen announces changes to its Executive Committee
GlobeNewswire
·
July 23, 2025
PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the following changes to its Executive Committee: Mari Scheiffele is appointed to EVP, Chief Product Officer Andreas Gerber …
Ipsen annonce des changements au sein de son Comité Exécutif
GlobeNewswire
·
July 23, 2025
PARIS, FRANCE, 23 juillet 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), groupe biopharmaceutique mondial de spécialité, annonce aujourd'hui les changements suivants au sein de son Comité Exécutif : Mari Scheiffele est nommée Vice-Présidente Exécutive, …
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire
·
July 23, 2025
ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …
Carestream Secures Partnership with Leading Distributor in Vietnam
GlobeNewswire
·
July 23, 2025
ROCHESTER, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Carestream Health recently secured an agreement with Vietnam South East Asia Joint Stock Company (VISTACOM), a leading distributor of advanced medical equipment solutions in Vietnam. “We are honored to …